3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Venous Thromboembolism
1
Neoplasms
1
Interventions
Dalteparin
8
apixaban
6
Rivaroxaban
6
Heparin, Low-Molecular-Weight
5
Tinzaparin
4
Enoxaparin
4
bemiparin
2
abelacimab
2
Warfarin
2
MAA868
2
Aspirin
2
reviparin
1
isoquercitrin
1
edoxaban
1
certoparin
1
betrixaban
1
argatroban
1
acarboxyprothrombin
1
Phenprocoumon
1
Nadroparin
1
N(4)-oleylcytosine arabinoside
1
Dabigatran
1
Acenocoumarol
1
AVE 5026
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Venous Thromboembolism
×
AVE 5026
×
Clear all
NCT00694382
2013-01-23
SAVE-ONCO
Sanofi
Phase 3
Completed
3,212 enrolled